Peripheral Neuropathy Trial, Recruiting NCT06672458 Sponsor: University of Miami Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06672458
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a traumatic spinal cord injury at or above the T1 level (roughly the upper back or neck), either within the last 6 months (and considered medically stable) or more than 6 months ago, with any level of impairment severity.
  • People who have had a peripheral nerve injury (with or without a spinal cord injury) and are either before or after surgery to transfer nerves in the arm or hand — either within 6 months of that surgery (considered medically stable and appropriate to participate by their neurosurgeon) or 6 or more months after surgery.
  • People who show at least some response in an arm or hand muscle on the affected side when electrical stimulation is applied to that muscle, confirmed at a baseline assessment.
  • People who show at least some detectable voluntary muscle activity in at least one arm or hand muscle on the affected side, confirmed by electrical muscle testing at a baseline assessment.
  • For one part of the study only: people who are able to commit to treatment and assessment sessions over a period of up to 4 months.

Who may not be able to join:

  • People who have a traumatic brain injury, stroke, multiple sclerosis, or another condition that could affect how the nerves and muscles work.
  • People with severe muscle stiffness or spasms that could prevent them from taking part in the study, as assessed by the investigator.
  • People with significant difficulties in thinking, memory, or mental health — including dementia, major depression, or other serious medical conditions affecting cognition.
  • People for whom electrical skin stimulation would not be safe — for example, those with broken or damaged skin where the electrodes would be placed, blood clots, or a skin disease in the relevant area.
  • People with poorly controlled autonomic dysreflexia (a condition involving sudden high blood pressure) that could be triggered by electrical stimulation.
  • People with an unhealed bone fracture, joint stiffening, or pressure sore in the arm or hand.
  • People who have an implanted nerve stimulation device, such as a deep brain stimulator or vagal nerve stimulator.
  • People who have a cardiac pacemaker or electrical lines inside the heart.
  • People who require other treatments or care that could interfere with taking part in the study.
  • People who are currently taking experimental drugs or other treatments known to affect nerve and muscle function.
  • People with substance use disorders, including alcohol or drug dependency.
  • People who are pregnant, breastfeeding, or planning to become pregnant during the study period.
  • People who the investigators consider unsuitable or unsafe for the study for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Matija Milosevic, PhD, University of Miami

Phone: (305) 243-9301

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
31 January 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Nine Hole Peg Test; Surface EMG; Graded-Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) Prehension Performance (GR-PP); Manual Muscle Test (MMT) with FES

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov